Smarter data, faster decisions: How biotech funding pressures are reshaping clinical development

Summary

The article discusses how biotech companies are adjusting clinical development strategies in response to funding pressures, focusing on generating earlier data to maintain investor confidence. No specific companies, drugs, or catalysts are mentioned.